Peyman Obeidy

Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo

David B. Lovejoy, Danae M. Sharp, Nicole A. Seebacher et al. · Journal of Medicinal Chemistry · 2012 · 199 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

The Iron Chelator, Deferasirox, as a Novel Strategy for Cancer Treatment: Oral Activity Against Human Lung Tumor Xenografts and Molecular Mechanism of Action

Goldie Y.L. Lui, Peyman Obeidy, Samuel Ford et al. · Molecular Pharmacology · 2012 · 137 citations

Medicine, Cancer Biology, Pharmacology +15

Deferasirox (<scp>ICL670A</scp>) effectively inhibits oesophageal cancer growth <i>in vitro</i> and <i>in vivo</i>

Peyman Obeidy, DB Lovejoy, Matthew Bedford et al. · British Journal of Pharmacology · 2012 · 81 citations

Medicine, Oncology, Pharmacology +14

Partial loss of actin nucleator actin‐related protein 2/3 activity triggers blebbing in primary T lymphocytes

Peyman Obeidy, Lining Arnold Ju, Stefan H. Oehlers et al. · Immunology and Cell Biology · 2019 · 38 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Ultra-stable Biomembrane Force Probe for Accurately Determining Slow Dissociation Kinetics of PD-1 Blockade Antibodies on Single Living Cells

Chenyi An, Wei Hu, Jie Gao et al. · Nano Letters · 2020 · 29 citations

Medicine, Oncology, Pharmacology +17